CETUXIMAB FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER

被引：1
|
作者：
Ubago, R. [1 ]
Castillo, M. A. [1 ]
Flores, S. [2 ]
Rodriguez, R. [1 ]
Beltran, C. [1 ]
机构：
[1] Agencia Evaluac Tecnol Sanitarias Andalucia, Seville, Andalucia, Spain
[2] Andalusian Agcy Hlth & Technol Assessment, Seville, Andalucia, Spain
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1104
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A433 / A434
页数：2
相关论文
共 50 条
  • [11] Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States
    Shankaran, Veena
    Ortendahl, Jesse D.
    Purdum, Anna G.
    Bolinder, Bjorn
    Anene, Ayanna M.
    Sun, Gordon H.
    Bentley, Tanya G. K.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (01): : 65 - 72
  • [12] Cetuximab plus FOLFIRI as first-line treatment for metastatic colorectal CA.
    Rougier, P
    Raoul, JL
    Van Laethem, JL
    Peeters, M
    Husseini, F
    Brezault, C
    Cals, L
    Vedovato, JC
    Mueser, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 248S - 248S
  • [13] Optimizing the first-line treatment for metastatic colorectal cancer
    Cherri, Sara
    Oneda, Ester
    Zanotti, Laura
    Zaniboni, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [14] Optimizing the first-line treatment for metastatic colorectal cancer
    Ciardiello, Davide
    Petrillo, Angelica
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [15] Cetuximab observational study as first-line therapy in patients with metastatic colorectal cancer
    Itabashi, Michio
    Tani, Kimitaka
    Muro, Kei
    Masuishi, Toshiki
    Ohashi, Yasuo
    Sugihara, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [16] Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    CLINICAL COLORECTAL CANCER, 2008, 7 (02) : 110 - 117
  • [17] Effectiveness and Safety of Cetuximab as First-line Treatment in the Elderly with Metastatic Colorectal Cancer from the EREBUS Cohort
    Fourrier-Reglat, Annie
    Noize, Pernelle
    Rouyer, Magali
    Smith, Denis
    Francois, Eric
    Monnereau, Alain
    Balestra, Aurelie
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 310 - 310
  • [18] NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy
    Rinaldi, Fiona
    George, Elisabeth
    Adler, Amanda I.
    LANCET ONCOLOGY, 2012, 13 (03): : 233 - 234
  • [19] COST-EFFECTIVENES OF CETUXIMAB IN FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER IN BELGIUM AND THE NETHERLANDS
    Krol, M.
    Ovcinnikova, O.
    von Hohnhorst, P.
    Jarrett, J.
    VALUE IN HEALTH, 2015, 18 (07) : A464 - A464
  • [20] Cetuximab A Guide to Its Use in Combination with FOLFIRI in the First-Line Treatment of Metastatic Colorectal Cancer in the USA
    Lyseng-Williamson, Katherine A.
    MOLECULAR DIAGNOSIS & THERAPY, 2012, 16 (05) : 317 - 322
12345